Sulbactam
Back to searchMolecule Structure
Scientific Name
Sulbactam
Description of the Drug
Sulbactam is an beta-lactamase inhibitor antibiotic combined with other antibiotics to treat a variety of susceptible bacterial infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09324
http://www.drugbank.ca/drugs/DB09324
Brand Name(s)
Not Available
Company Owner(s)
Wytells Pharma Private Ltd, Mylan Laboratories Ltd, Sandoz Inc, Pharmaceutical Associates Inc, Hospira Inc, Hq Specialty Pharma Corp, Pfizer Laboratories Div Pfizer Inc, Istituto Biochimico Italiano Spa, Acs Dobfar Spa, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial beta-lactamase TEM | SINGLE PROTEIN | INHIBITOR | CHEMBL2364670 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL47781 | |
DrugBank | DB09324 | |
PubChem: Thomson Pharma | 15121712 | 14847263 |
PubChem | 130313 | |
Mcule | MCULE-8384465258 | |
LINCS | LSM-5553 | |
Nikkaji | J689.013J | J19.104C |
PDBe | 0RN | |
BindingDB | 50021954 | |
EPA CompTox Dashboard | DTXSID1023605 | |
DrugCentral | 2492 | |
Brenda | 1420 | 105742 |
ChemicalBook | CB1419201 | |
Guide to Pharmacology | 10769 | |
rxnorm | SULBACTAM SODIUM | SULBACTAM |
KEGG Ligand | C07770 | |
ChEBI | 9321 | |
ZINC | ZINC000000897244 |